Trellus Management Company, LLC Amarin Corp Plcuk Transaction History

Trellus Management Company, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$4.04 - $5.31 $202,000 - $265,500	-50,000 Closed	0 $0
Q3 2020 Oct 20, 2020	BUY	$3.64 - $7.76 $36,036 - $76,824	9,900 Added 24.69%	50,000 $211,000
Q1 2020 May 06, 2020	BUY	$4.0 - $21.53 $40,000 - $215,300	10,000 Added 33.22%	40,100 $160,000
Q4 2019 Feb 20, 2020	BUY	$13.94 - $24.12 $140,794 - $243,612	10,100 Added 50.5%	30,100 $645,000
Q3 2019 Nov 01, 2019	SELL	$13.89 - $23.16 $277,800 - $463,200	-20,000 Reduced 50.0%	20,000 $303,000
Q2 2019 Jul 31, 2019	BUY	$16.27 - $20.51 $162,700 - $205,100	10,000 Added 33.33%	40,000 $776,000
Q1 2019 Apr 23, 2019	BUY	$12.61 - $22.33 $378,300 - $669,900	30,000 New	30,000 $623,000

176

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $222M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Trellus Management Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Trellus Management Company, LLC with notifications on news.